- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: ER/PR/HER2 negative
Total 15899 results
-
AstraZenecaActive, not recruitingER+ HER2- Advanced Breast CancerJapan
-
AstraZenecaCompletedER+ HER2- Advanced Breast CancerUnited States, United Kingdom, Korea, Republic of
-
Dartmouth-Hitchcock Medical CenterRecruitingAdvanced Breast CancerUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyCompletedMetastatic Breast CancerUnited States
-
Fudan UniversityJiangsu HengRui Medicine Co., Ltd.CompletedMetastatic Breast CancerChina
-
Eisai Co., Ltd.Active, not recruiting
-
Clovis Oncology, Inc.TerminatedBreast Cancer | Metastatic Breast Cancer | Estrogen Receptor Positive | Triple Negative | HER2 | HER2 Positive | MBC | ERUnited States
-
Novartis PharmaceuticalsCompletedAdvanced, Metastatic Breast CancerUnited States, Canada, France, Italy, Spain, Taiwan, Hungary, Turkey, Belgium, Germany, Netherlands, Singapore, Austria, Czechia, Australia, Israel, Russian Federation, Sweden, United Kingdom, Korea, Republic of, Thailand, Lebanon, ... and more
-
AstraZenecaActive, not recruitingER-Positive HER2-Negative Breast CancerAustria, Belgium, France, Germany, Italy, United Kingdom, United States, Canada, India, Taiwan, Russian Federation, Korea, Republic of, Hungary, Japan, Mexico, Turkey, China, Malaysia, Spain, Czechia, Portugal, Poland, Norway, Bulgaria, Slovaki... and more
-
Stemline Therapeutics, Inc.CompletedAdvanced ER+, HER2-Negative Breast CancerUnited States
-
Organisation for Oncology and Translational ResearchUnknownLetrozole and CDK 4/6 Inhibitor for ER Positive, HER2 Negative Breast Cancer in Postmenopausal WomenER Positive, HER2 Negative Breast CancerChina
-
Hebei Medical University Fourth HospitalRecruiting
-
Applied Spectral Imaging Ltd.Completed
-
Royal Marsden NHS Foundation TrustPfizer; AstraZeneca; Institute of Cancer Research, United Kingdom; UNICANCER; Gustave... and other collaboratorsRecruitingHER2-negative Breast Cancer | ER+ Breast CancerUnited Kingdom, France
-
Bristol-Myers SquibbCompletedBreast Cancer | MetastasisUnited States, Spain, Belgium, Peru, Italy, Argentina, France
-
The Methodist Hospital Research InstituteEli Lilly and CompanyRecruitingHER2-negative Breast Cancer | ER-Positive Breast CancerUnited States
-
Stanford UniversityUnited States Department of DefenseRecruitingBreast Cancer | HER2-negative Breast Cancer | ER Positive Breast CancerUnited States
-
AstraZenecaActive, not recruitingAdvanced ER-Positive HER2-Negative Breast CancerUnited States, Italy, Spain, Belgium, Poland, Canada, Germany, Korea, Republic of, Russian Federation, France, Israel, Hungary, Portugal, United Kingdom, Georgia, Ukraine
-
University of Colorado, DenverPfizer; Criterium, Inc.; Cascadian Therapeutics Inc.CompletedBreast CancerUnited States
-
AstraZenecaAustrian Breast and Colorectal Cancer Study Group (ABCSG)RecruitingBreast Cancer, Early Breast CancerUnited States, Spain, Italy, Korea, Republic of, Belgium, Canada, Poland, Portugal, United Kingdom, France, China, Germany, Japan, Mexico, Thailand, Hungary, Australia, Austria, Brazil, Colombia, Taiwan, Malaysia, Philippines, Romania, ... and more
-
Ahon Pharmaceutical Co., Ltd.Zhejiang Cancer Hospital; Fudan University; Sir Run Run Shaw HospitalUnknown
-
G1 Therapeutics, Inc.CompletedBreast Cancer | Advanced Breast Cancer | Breast Neoplasm | Metastatic Breast Cancer | Stage IV Breast Cancer | Carcinoma, Ductal, Breast | Breast Cancer FemaleUnited States, Belgium, Bulgaria, Georgia, Netherlands, Moldova, Republic of, Ukraine
-
Shanghai Hengrui Pharmaceutical Co., Ltd.RecruitingER-Positive, HER2-Negative Breast CancerChina
-
AstraZenecaQuotient SciencesCompletedER-positive, HER2-negative Breast CancerUnited Kingdom
-
KU LeuvenNovartisUnknownER Positive, HER2 Negative Breast Cancer NeoplasmsBelgium
-
Sun Yat-sen UniversityRecruiting
-
Ahon Pharmaceutical Co., Ltd.Affiliated Hospital of Hebei University; The First Hospital of Jilin University and other collaboratorsRecruiting
-
University of MiamiRecruitingBreast Cancer | Metastatic Breast Cancer | ER-positive Breast Cancer | HER2-negative Breast CancerUnited States
-
UNICANCERWithdrawnER-positive Her2-negative Early Breast Cancer
-
AstraZenecaRecruitingBreast Cancer, Early Breast CancerUnited States, Canada, United Kingdom, China, Argentina, Australia, Hungary, Netherlands, Korea, Republic of, France, Germany, Italy, Belgium, Bulgaria, India, Mexico, Spain, Vietnam, Colombia, Japan, Peru, Brazil, Malaysia, Taiwan, Tha... and more
-
University of PittsburghRecruitingBreast CancerUnited States
-
Shengjing HospitalJiangsu HengRui Medicine Co., Ltd.Not yet recruitingER Positive/HER2 Low Breast CancerChina
-
Janssen Research & Development, LLCCompletedPostmenopausal | Metastatic ER+ Her2- Breast CancerUnited States, France, Ukraine, United Kingdom, Belgium, Spain, Netherlands, Korea, Republic of, Russian Federation, Poland, Luxembourg, Ireland
-
University of Texas Southwestern Medical CenterCancer Prevention Research Institute of TexasActive, not recruitingBreast Cancer FemaleUnited States
-
Ruijin HospitalJiangsu HengRui Medicine Co., Ltd.UnknownBreast Cancer | HER2-positive Breast Cancer | ER-positive Breast Cancer
-
Jiangsu HengRui Medicine Co., Ltd.TerminatedER+ / HER2- Advanced Breast CancerChina
-
University of Wisconsin, MadisonMillennium Pharmaceuticals, Inc.CompletedPost Menopausal, Hormone Receptor Positive Breast CancerUnited States
-
University of ChicagoGenentech, Inc.TerminatedMetastatic Breast CancerUnited States
-
SanofiUNC Lineberger Comprehensive Cancer CenterCompletedBrain Metastases | Estrogen Receptor Negative (ER-Negative) Breast Cancer | Progesterone Receptor Negative (PR-Negative) Breast Cancer | Human Epidermal Growth Factor Receptor 2 Negative (HER2-Negative) Breast CancerUnited States
-
Guangdong Provincial People's HospitalUnknown
-
Novartis PharmaceuticalsCompletedAdvanced Metastatic Breast CancerCanada, Italy, Hungary, Taiwan, Turkey, Belgium, Germany, Spain, United States, Singapore, Australia, Korea, Republic of, Hong Kong, Thailand, Lebanon, Bulgaria, France, Russian Federation, Argentina, Brazil, Malaysia, Portugal, Col... and more
-
Fondazione Sandro PitiglianiClinical Research Technology S.r.l.RecruitingMetastatic Breast Cancer | HER2-negative Breast Cancer | ER Positive Breast CancerItaly
-
Imperial College LondonMedical Research Council; ECMCRecruitingMetastatic Breast Cancer | HER2-negative Breast Cancer | ER Positive Breast CancerUnited Kingdom
-
Cedars-Sinai Medical CenterAstraZenecaWithdrawnBreast Cancer | Triple Negative Breast CancerUnited States
-
MedSIRStemline Therapeutics, Inc.Not yet recruitingAdvanced Breast Cancer | ER-positive Breast Cancer | HER2-negative Breast Cancer | ESR1 Gene Mutation
-
Northwestern UniversityNational Cancer Institute (NCI); AmgenTerminatedStage IV Breast Cancer | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Positive | Breast Carcinoma Metastatic in the Bone | Circulating Tumor Cell CountUnited States
-
Instituto do Cancer do Estado de São PauloRecruiting
-
Memorial Sloan Kettering Cancer CenterContext Therapeutics Inc.Active, not recruitingGranulosa Cell Ovarian Cancer | Low Grade Serous Ovarian/ Primary Peritoneal Cancer | Endometrioid Endometrial CancerUnited States
-
Emory UniversityTerminatedBreast Cancer | Breast Neoplasms | Cancer of the BreastUnited States